Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Sun-Pharma"

151 News Found

Sun Pharma launches novel cough medicine
Drug Approval | September 28, 2021

Sun Pharma launches novel cough medicine

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug


Sun Pharma Consumer Healthcare launch Revital NXT nutrition bar
Healthcare | September 08, 2021

Sun Pharma Consumer Healthcare launch Revital NXT nutrition bar

The company said Revital NXT is India’s first nutrition bar with the goodness of natural ginseng, 16 vitamins & minerals and triple blend protein


Sun Pharma Industries announce sale of Kayaku
News | September 02, 2021

Sun Pharma Industries announce sale of Kayaku

The company has been sold to Shinshin Pharmaceuticals


Sun Pharma Advanced Research Company gets board approval to raise Rs 1,800 crore
News | September 02, 2021

Sun Pharma Advanced Research Company gets board approval to raise Rs 1,800 crore

At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.


Sun Pharma to commercialise Winlevi in the US and Canada
News | August 31, 2021

Sun Pharma to commercialise Winlevi in the US and Canada

Acne affects up to 50 million Americans annually. The last FDA approval of an acne drug with a new MOA occurred nearly 40 years ago


Sun Pharma Speciality business looks encouraging: HDFC Securities
News | August 13, 2021

Sun Pharma Speciality business looks encouraging: HDFC Securities

Winlevi, the recently added anti-acne product with a new mechanism of action and broad-based use (vs Absorica), will further boost the derma portfolio and Speciality business growth


Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr
News | July 31, 2021

Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr

It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.


Sun Pharma signs Cassiopea for license and supply agreements
News | July 27, 2021

Sun Pharma signs Cassiopea for license and supply agreements

Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older


Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr
News | July 27, 2021

Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.


Sun Pharma launches 'Sunkalp' on National Doctors' Day
News | July 01, 2021

Sun Pharma launches 'Sunkalp' on National Doctors' Day

Sun Pharma has committed Rs. 100 crores towards these initiatives